NCT01036087 2023-03-30
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
M.D. Anderson Cancer Center
RenJi Hospital
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC